EU Commission approves first RSV vaccine for people over 60
A recommendation from the EMA’s expert panel from earlier this year has now been cemented.
- Pfizer’s RSV shot wins US approval following GSK’s to market
- First RSV vaccine caps 60-year search to stem pervasive lung illness
For subscribers